HGF and cancer: The inhibition of mammary cancer cell growth was associated with the ability of (-)-oleocanthal treatment to block c-Met receptor activation in response to its natural ligand HGF in MDA-MB-231, MCF-7, and BT474 cancer cell lines in culture.